SAN FRANCISCO, July 14, 2024 — AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies, with the goal of achieving functional cure for chronic hepatitis B (CHB) infection, today announced the completion of a $37 million Series A financing round. This round was led by existing investor, InnoPinnacle Fund, with participation from new investors including Yuanbio Venture Capital, Qiming Venture Partners, Hankang Capital, and Genesis Capital.

The proceeds from the financing will further support the clinical development of AHB-137, AusperBio’s lead product candidate. Additionally, the funds will advance its proprietary Med-Oligo™ technology platform and its product pipelines.

Dr. Guofeng Cheng, co-founder and CEO of AusperBio, commented: “We are immensely grateful for the continued support from our existing investors and are very pleased to welcome new investors to the company. This financing round represents a significant milestone that recognizes our scientific and clinical achievements to date. The shared commitment from our investors to developing new therapeutics for CHB patients is truly inspiring. With this funding, together with the recent Breakthrough Therapy Designation (BTD) from China’s CDE, we are well-positioned to rapidly advance the clinical development of AHB-137 and move closer to providing a vital new treatment option for patients with CHB.”

About AHB-137

AHB-137, a novel unconjugated antisense oligonucleotide (ASO) developed within AusperBio’s proprietary Med-Oligo™ ASO technology platform, was designed to treat chronic hepatitis B for a functional cure. Its compelling preclinical and Phase 1 clinical data was highlighted at the 2023 EASL™ conference and the 2024 EASL™ conference, respectively. This novel dual-mechanism ASO is presently undergoing a Phase 1b trial across multiple international study sites and a concurrent Phase 2 trial in China. Through a global development strategy, AHB-137 is advancing rapidly towards the goal of HBV cure.

About AusperBio.

AusperBio is a clinical-stage biopharmaceutical company with operations in the USA and China, dedicated to advancing oligonucleotide and targeted delivery technologies for transformative therapies, with an initial focus on curing chronic hepatitis B infection. The company has developed a proprietary Med-Oligo™ ASO platform which has been shown to substantially enhance the current ASO therapeutics, through novel insights into ASO design. Combining with efficient targeted delivery conjugation technologies, the modular Med-Oligo™ Platform empowers ASO therapeutics to treat a broad range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.

For further information, please contact:

Media Contact
Email: [email protected]

Investor Relations Contact:
Tel: 650-888-1756 (US)
Email: [email protected]

SOURCE AusperBio Therapeutics Inc.

Available to Media Outlets Globally for Fraud Management and Prevention Expertise

NEW YORK, July 12, 2024 — Fraud.net, an award-winning fraud and risk management platform, is excited to announce that Whitney Anderson, its CEO and co-founder, has been dubbed one of Cybersecurity Ventures 2024 Pundits. The inaugural 2024 List of Cybersecurity Pundits features experts with deep domain expertise in one or more technical categories. The Pundits also have experience analyzing topics and stories, providing media outlets with thoughtful and thorough comments.

Whitney Anderson leverages 25+ years of experience in applied AI, advanced analytics, and real-time payments to drive game-changing value for organizations. He is a sought-after speaker and thought leader on AI safety, fraud, and risk.

On being included in the list, Anderson stated: “I am excited to be joining this elite team of experts recognized by Cybersecurity Ventures. I look forward to sharing valuable insights and commentary with any media outlet seeking to navigate the complexities of fraud management and prevention.”

Reporters and Journalists, contact Whitney Anderson here.

About Fraud.net:

Fraud.net operates a unified fraud, AML, and digital risk management platform for financial services and digital commerce enterprises worldwide. The cloud-born platform helps organizations dramatically reduce fraud, false positives, and financial crime and automates customer onboarding and compliance workflows. The platform leverages a no-code/low-code architecture, offers natively integrated data and tools from 50+ leading 3rd Party specialists, and relies on custom AI models to enable companies to make safer, smarter, and more profitable decisions.

To learn more, visit Fraud.net.

About Cybersecurity Ventures

Cybersecurity Ventures is the leading researcher and authoritative source for global cyber economy insights, providing crucial data, statistics, and predictions to a diverse audience including CIOs, IT executives, CSOs, CISOs, cybersecurity practitioners, company founders, CEOs, venture capitalists, investors, business executives, HR professionals, and government cyber defense leaders. Through Cybercrime Magazine, it publishes comprehensive reports on global cybercrime, market forecasts, spending predictions, company data, venture funding, mergers, acquisitions, and employment trends. Its content is based on extensive original research and vetted information from credible sources, with no “pay-to-play” or “advertorial” content.

View the list of 2024 List of Cybersecurity Pundits.

SOURCE fraud.net

*Accelerating Global Expansion and Growth*

SEOUL, South Korea, July 12, 2024 — On July 12, Miridih Co., Ltd. (hereinafter referred to as Miridih) announced that it has successfully secured new funding through a Series B investment. Miridih is well-known for its SaaS-based design platform, MiriCanvas, which boasts 13 million users, making it the largest of its kind in South Korea.

The total investment amounting to KRW 20 billion (approximately USD 15 million) included participation from Kiwoom PE, Industrial Bank of Korea(IBK), Shinhan Venture Investment, and G.N. Tech Venture Capital. With this investment, Miridih’s post-money valuation has been recognized at KRW 280 billion (approximately USD 215 million), raising expectations for its growth and innovation. G.N. Tech Venture Capital, in particular, highly evaluated Miridih’s domestic success and global potential, actively considering a follow-on investment. The investment was made through the issuance of Redeemable Convertible Preferred Shares(RCPS).

Miridih plans to utilize the newly raised funds for talent acquisition and global marketing to further accelerate its global expansion. CEO Kang Changseok of Miridih stated, “We are delighted to introduce MiriCanvas, the largest design platform in Korea, to the global market. With this investment, we aim to lead the innovation of the global design ecosystem and create a convenient design culture, both domestically and internationally.”

Founded in 2008, Miridih has successfully established itself in the domestic market with its SaaS-based design platform ‘MiriCanvas’ and POD printing service ‘BizHows.’ The company has shown remarkable growth each year, attracting significant attention. Miridih recorded sales of KRW 14.7 billion in 2020, KRW 19.3 billion in 2021, KRW 33.1 billion in 2022, and KRW 60.7 billion (with an operating profit of KRW 7.7 billion) last year in 2023, continuing its explosive upward trend. This investment is expected to further accelerate its growth, marking a crucial milestone in its journey to becoming a global unicorn company.

Meanwhile, Miridih announced plans to select an IPO underwriter in the second half of 2024 and officially begin preparations for its IPO.

CONTACT: Yeongmin Heo, COO, Josh Inseung Yoon, CFO, [email protected] 

SOURCE Miridih

KATY, Texas, July 11, 2024 — 406 Bovine, a provider of facial recognition software for livestock, is leading the adoption of artificial intelligence in animal agriculture applications.

Early applications for artificial intelligence in agriculture have been focused on row crop and land management applications. However, applications to animal agriculture are gaining attention as producers realize the value that can be generated and captured by implementing technology that utilizes artificial intelligence into their operations.

USDA estimates that the total market value of livestock in 2022 was more than $260 billion with most of the value in beef cattle ($89 billion) followed by dairy ($52 billion), hogs and pigs ($36 billion), sheep and goats ($1.1 billion), and horses ($2 billion).

Artificial intelligence applications in animal agriculture fall into several primary categories: value creation, value capture, and cost savings. Specific artificial intelligence applications range from animal identification and weight determination to optimizing genetics and feed intake to increase production efficiency and market value.

The 406 Bovine facial recognition solution is focused on animal identification and uses a database of more than six million animal images to train its artificial intelligence algorithms to identify individual animals quickly and reliably. After extensive field testing and model improvement, the 406 Bovine application is operating with more than 99% accuracy across all common cattle breeds.

406 Bovine has a Patent Cooperation Treaty (PCT), multi-nation patent pending in the U.S on animal facial recognition. This patent is the first and only livestock biometrics patent which enables fast, accurate, and permanent animal identification using facial recognition to identify livestock and companion animals.

Ranchers invest time and money to make incremental herd improvements. Most ranchers use ear tags to track and manage individual animals. However, losing that tag means a loss of identification and exclusion from many value-added programs.

By utilizing 406 Bovine facial recognition, ranchers maintain individual animal identification and capture the value they have added to their herds. The 406 Bovine app is used to improve management of cattle herds and track important information that helps ranchers make informative decisions that aid in making critical management choices. All the information collected may be stored and accessed on their smartphone.

Bryan Elliott, founder and CEO of 406 Bovine, said: “Artificial intelligence in animal production is in its infancy but we have already seen 406 Bovine customers use facial recognition to track program cattle with added value, replace DNA identification, and streamline data collection.”

Elliott continued, “406 Bovine is the only true permanent, individual animal identification option on the market, so our customers use the technology for a wide range of applications, from replacing brands and ear tags to serving as a backup identification method for program-specific cattle. Our customers are continually finding new and innovative ways to apply facial recognition technology to their operations, and we will continue to update the 406 Bovine service to meet their evolving needs.”

The resources required to design, build, test, and implement artificial intelligence solutions are significant. 406 Bovine has raised funds from angel investors and is currently accepting investors for subsequent funding rounds.

Elliott noted: “As artificial intelligence utility increases and technology unit costs decrease, we believe 406 Bovine is positioned for long-term growth as a leading provider of artificial intelligence solutions to animal agriculture.”

About 406 Bovine
406 Bovine is an agricultural technology company providing facial recognition software which rapidly and accurately identifies livestock by capturing animal-specific facial data. Using advanced artificial intelligence, 406 Bovine empowers livestock producers to record animal identification and related information in a proprietary, patented API.

For more information, please visit www.406bovine.com.

Contact
Bryan Elliott
Founder and CEO
832-271-0771, ext. 800
[email protected]

SOURCE 406 Bovine

BOULDER, Colo., July 11, 2024 — AVL Growth Partners, known since 2009 as a fractional finance and accounting company supporting organizations in pivoting from grow to scale, has launched a new service offering: fractional human resources. Whether a growing company needs foundational, tactical, strategic, or executive-level support, AVL provides the full continuum of HR services as needed.

“In our work with clients, it became evident they needed support not just with business finances, but also with the ‘people’ side of things,” explains CEO Bethany Parker. “Our goal is to help early to late-stage companies maximize organizational effectiveness with our experienced HR talent, from generalists to Chief People Officers.”

“The beauty of the fractional model,” adds Head of Professional Services, Blair Drake, “is that founders and executives can get the tactical and executive-level help they need to bolster a rapidly growing company without the overhead of full-time resources. This is our formal launch, and our current clients have been successfully using the offering for the last six months.”

The newly launched HR services are designed to manage all your HR needs and propel your business growth. From strategic people planning and targeted development to enhancing productivity, satisfaction, and retention with a strong DEI focus, our HR experts leverage cutting-edge HR operations and analytics.

We manage everything from core HR setup and talent management to total rewards compensation, allowing leaders to focus on strategic goals. Our expert guidance on compensation, benefits, and talent acquisition ensures your company gains a competitive edge.

The AVL Mindful Growth Methodology now spans accounting and finance as well as human resources. We evaluate practices, assess impact, and implement strategic roadmaps with regular reviews and quarterly evaluations to refine growth strategies based on performance data and market trends.

“Over the last 15 years, we have served more than a thousand early-stage companies and found that clients experiencing success with our finance and accounting offering ran into people and culture issues they sought to solve with a similar fractional model. We are delighted to bring this offering to market and continue supporting startups nationwide,” says Parker.

About AVL Growth Partners

AVL Growth Partners is a fractional finance, accounting, and human resources services company supporting growing companies in pivoting from grow to scale. For details, visit avlgrowth.com/human-resources or connect with us at 720-460-9289.

SOURCE AVL Growth Partners

PESCARA, Italie, 11 juillet 2024 — HUI a le plaisir d’annoncer la clôture d’un engagement de capitaux propres de 25 millions d’euros de la part de Nimbus Capital, un fonds basé au Panama. Cet investissement permettra à HUI de poursuivre sa croissance en tant que Super App VC 3.0, utilisée par des milliers d’entrepreneurs, de startups et d’investisseurs pour ses caractéristiques uniques sur le marché.

« HUI est une Super App unique, avec une base de code impressionnante de plus de 1,2 million de lignes de code, plus de 20 applications couvrant toutes les fonctions et processus commerciaux – des ventes aux RH, de la collecte de fonds à la gestion de projet, de l’intelligence au crowdfunding – le tout dans un environnement unique. Il ne nécessite aucune compétence en matière de codage pour fonctionner via une API avec des services externes, spécialement conçus pour chaque partie prenante sur la scène mondiale du capital-risque », explique Luigi Valerio Rinaldi, fondateur de HUI et président de Enry’s Island SpA.

L’approche de HUI, basée sur les données, la distingue des agrégateurs tels que Crunchbase, DealRoom et PitchBook. Contrairement à ces plateformes, le HUI ne fait pas appel à des robots d’indexation pour obtenir des données. En revanche, il dispose d’une base de données et d’un modèle de données complets, avec des fonctionnalités d’IA développées pour offrir une valeur significative en termes de recommandations et de prédictions.

« L’approche axée sur les données et les fonctionnalités de la blockchain et de l’IA prévues pour le troisième trimestre nous ont incités à investir dans HUI », déclare Robert J. Baker, associé gérant de Nimbus Capital. « Nimbus se consacre à l’identification des futures licornes et répond aux besoins avancés du paysage mondial du capital-risque. HUI correspond parfaitement à notre vision ».

Cette prise de participation de 25 millions d’euros s’inscrit dans le cadre du plan de développement de HUI, qui fait suite à une levée de fonds de 300 millions d’euros et à un partenariat commercial avec l’un des intégrateurs de systèmes informatiques les plus renommés au monde. Avec un nombre croissant d’écosystèmes de capital-risque adoptant HUI, et en préparation d’une cotation sur une bourse européenne, soutenue par une grande société de conseil, HUI vise à être la première plateforme tout-en-un de capital-risque 3.0 cotée au monde.

Cet investissement permettra d’accélérer considérablement la stratégie produit de HUI, en améliorant son utilisation de l’IA, de la Blockchain et des fonctionnalités 3.0 telles que le Metaverse et le Gaming. HUI développera également ses activités de marketing et de vente sur les marchés des États-Unis, d’Amérique latine, d’Afrique et d’Extrême-Orient.

L’engagement de capitaux permet également à Luigi V. Rinaldi de rejoindre Nimbus en tant que Venture Partner, mettant à profit ses 20 ans d’expérience dans le domaine du capital-risque pour renforcer le leadership financier et technologique de Nimbus.

« Je suis ravi de la profonde harmonie et de la vision commune avec Nimbus et son fondateur, Robert. Ce partenariat aura un impact significatif sur la scène mondiale du capital-risque », ajoute Luigi Valerio Rinaldi.

Contact avec les médias :

Équipe chargée des relations avec les investisseurs 
+39 3939774542
[email protected] 

Photo – https://mma.prnewswire.com/media/2458456/HUI_Equity_Commitment_Nimbus_Capital.jpg
Logo – https://mma.prnewswire.com/media/2458455/HUI_Logo.jpg

PESCARA, Italien, 11. Juli 2024 — HUI freut sich, den Abschluss einer Eigenkapitalzusage in Höhe von 25 Millionen Euro von Nimbus Capital, einem in Panama ansässigen Fonds, bekannt zu geben. Diese Investition wird das Wachstum von HUI als die VC 3.0 Super App weiter vorantreiben, die von tausenden von Unternehmern, Startups und Investoren aufgrund ihrer einzigartigen Marktmerkmale genutzt wird.

„HUI ist eine einzigartige Super App mit einer beeindruckenden Codebasis von über 1,2 Mio. Codezeilen und mehr als 20 Apps, die alle Geschäftsfunktionen und -prozesse abdecken – vom Vertrieb bis zur Personalabteilung, von der Mittelbeschaffung bis zum Projektmanagement, von Intelligenz bis zum Crowdfunding – alles in einer einzigen Umgebung. Es erfordert keine Programmierkenntnisse, um über API mit externen Diensten zu arbeiten, die speziell für jeden Akteur der globalen VC-Szene entwickelt wurden”, erklärt Luigi Valerio Rinaldi, Gründer von HUI und Vorsitzender von Enry’s Island SpA.

Der datengestützte Ansatz von HUI unterscheidet sich von Aggregatoren wie Crunchbase, DealRoom und PitchBook. Im Gegensatz zu diesen Plattformen stützt sich HUI nicht auf Crawler zur Datenbeschaffung. Stattdessen verfügt es über eine umfassende Datenbank und ein Datenmodell, wobei KI-Funktionen entwickelt werden, die einen erheblichen Mehrwert bei Empfehlungen und Vorhersagen bieten.

„Der datengetriebene Ansatz und die für Q3 geplanten Blockchain- und KI-Funktionen haben uns dazu bewogen, in HUI zu investieren”, sagt Robert J. Baker, Managing Partner bei Nimbus Capital. „Nimbus hat es sich zur Aufgabe gemacht, zukünftige Einhörner zu identifizieren und die fortgeschrittenen Bedürfnisse der globalen VC-Landschaft zu adressieren. HUI deckt sich perfekt mit unserer Vision”.

Die Kapitalbeteiligung in Höhe von 25 Millionen Euro ist Teil des Wachstumsplans von HUI, der auf eine Seed-Runde in Höhe von 300 000 Euro und eine kommerzielle Partnerschaft mit einem der renommiertesten internationalen IT-Systemintegratoren folgt. Mit einer zunehmenden Anzahl von VC-Ökosystemen, die HUI übernehmen, und in Vorbereitung auf eine Notierung an einer europäischen Börse, unterstützt von einem großen Beratungsunternehmen, zielt HUI darauf ab, die weltweit erste börsennotierte VC 3.0 All-in-One-Plattform zu werden.

Diese Investition wird die Produktstrategie von HUI erheblich beschleunigen und die Nutzung von KI, Blockchain und 3.0-Funktionen wie Metaverse und Gaming verbessern. HUI wird außerdem seine Marketing- und Vertriebsaktivitäten auf die Märkte in den USA, Lateinamerika, Afrika und dem Fernen Osten ausweiten.

Mit der Kapitalzusage kommt auch Luigi V. Rinaldi als Venture Partner bei Nimbus an Bord, der mit seiner 20-jährigen VC-Erfahrung die finanzielle und technologische Führungsposition von Nimbus weiter ausbaut.

„Ich bin begeistert von der tiefen Harmonie und der gemeinsamen Vision mit Nimbus und seinem Gründer Robert. Diese Partnerschaft wird erhebliche Auswirkungen auf die globale VC-Szene haben”, fügt Luigi Valerio Rinaldi hinzu.

Medienkontakt:

Investor Relations Team 
+39 3939774542
[email protected] 

Foto – https://mma.prnewswire.com/media/2458456/HUI_Equity_Commitment_Nimbus_Capital.jpg
Logo – https://mma.prnewswire.com/media/2458455/HUI_Logo.jpg

Strategic investment from Oak HC/FT and Cedars-Sinai Health Ventures will support the rapid expansion of Regard’s AI-powered clinical insights platform aimed at unlocking the full power of the EHR

LOS ANGELES, July 11, 2024 — Regard, the AI-powered clinical insights platform that empowers clinicians to unlock the full potential of patient data, announced today the close of a $61 million Series B financing round, led by Oak HC/FT, with participation from Cedars-Sinai Health Ventures, as well as existing investors TenOneTen Ventures, Calibrate Ventures, and Techstars. The investment will enable the company to accelerate product development with their core clinical insights platform, invest in fundamental research in large language models  (LLMs) and expand beyond inpatient facilities.

“Regard is positioned to revolutionize how we think about clinical decision-making support for doctors,” said Nancy Brown, General Partner at Oak HC/FT. “The team at Regard has built a platform that is driving value for patients, physicians and health systems alike by improving outcomes, increasing efficiency, reducing burnout, and increasing revenue. Eli and Nate have been thoughtful about product development and we are thrilled to be a part of this next chapter where they look to deliver this value at scale.”

An influx of new technologies has generated more healthcare data than ever, yet much of it remains untapped for clinical care. According to The World Economic Forum, less than 3% of available patient data is used by a physician. With an average of 50,000 data points per patient, the gap between the vast amount of data available and clinically actionable insights generated from it is significant. Regard bridges the clinical insights gap by analyzing all available data and recommending diagnoses, enabling clinicians to deliver better care. Once recommendations are reviewed and approved by the clinician, Regard ensures complete and accurate documentation in a standardized format, a critical step to ensure clinical quality and enhance hospital revenue. 

“Cedars-Sinai has been working alongside Regard from the early days of the business because we saw a real need to empower physicians with the data that can provide critical analysis and insights to assist in diagnosis and treatment,” said Maureen Burgess, Partner at Cedars-Sinai Health Ventures. “And, even more importantly, we believe it will improve patient care as well as the patient experience.”

Since its launch in 2021, Regard’s technology has surfaced more than three million diagnoses to care teams and generated more than $50 million in incremental revenue for enterprise health system partners including Banner Health and Sentara. Most recently, the company announced a partnership with WakeMed Health & Hospitals, a leading health system in Raleigh, North Carolina.

“Imagine a doctor having all the EHR information they need about a patient, right in front of them, in just seconds. Regard is augmenting patient care by analyzing overwhelming mountains of clinical data and providing clinicians with potential diagnoses and treatment recommendations, impacting the quality and safety of care in real-time,” said Eli Ben-Joseph, CEO at Regard. “That’s a game-changer – not just for doctors, but for the people whose lives are in their hands.”

About Regard
Regard, the leading AI clinical insights platform, unlocks the full potential of patient data.  Regard’s clinical intelligence layer drives the future of healthcare by augmenting clinical workflows and turning data into actionable insights. The technology helps health systems get the most value out of their clinical data: improving patient care, saving physicians time, and rejuvenating hospital finances. Regard is carving a path forward for health systems and physicians to meaningfully leverage AI, with the goal of empowering physicians to provide world-class healthcare to everyone.

About Oak HC/FT
Oak HC/FT is a venture and growth equity firm specializing in investments in fintech and healthcare. Using partnership as a foundation, Oak HC/FT guides companies and founders at every stage, from seed to growth, to create businesses that make a measurable and lasting impact. Founded in 2014, Oak HC/FT has invested in over 85 portfolio companies and has over $5.3 billion in assets under management. Oak HC/FT is headquartered in Stamford, CT, with an office in San Francisco, CA. Follow Oak HC/FT on LinkedIn and X and learn more at https://www.oakhcft.com/.

Media contact:
Dori Young
[email protected]

SOURCE Regard

The award based on data analysis of specific KPIs was given to 250 of the top fintech firms from around the world

BOULDER, Colo. and NEW YORK, July 11, 2024 — TIFIN, an early mover and leading innovator in AI-powered fintech applications, has been honored as one of CNBC’s “The World’s Top Fintech Companies 2024” recipients. TIFIN is listed among 250 of the world’s top companies across wealth technology, payments, digital assets, neobanking, financial planning, and other categories. CNBC partnered with Statista to create the list based on the independent journalistic criteria of CNBC and Statista as well as “the analysis and weighting of overarching and segment-specific KPIs.¹“

The full list of winners can be found on cnbc.com:

https://www.cnbc.com/the-worlds-top-250-fintech-companies-2024/

For more information about TIFIN and its AI-powered fintech platform, please visit www.tifin.com.

¹ Award Methodology:

https://fm.cnbc.com/applications/cnbc.com/resources/editorialfiles/2024/07/08/CNBCs_Worlds_Top_FinTech_Companies_2024_-_Methodology.pdf

About TIFIN

TIFIN is an AI platform for wealth. TIFIN creates and operates companies that apply data science, AI, and technology to address frictions in wealth and asset management. TIFIN’s companies have included 55ip (sold to JP Morgan), Paralel and currently include Magnifi, TIFIN Wealth, TIFIN Give, TIFIN AG, TIFIN AMP, Sage, Helix, and TIFIN @Work. TIFIN has been backed by JP Morgan, Morningstar, Hamilton Lane, Franklin Templeton, and SEI among others.

Media Contacts

Michael Walsh

[email protected]

AJ Boury

[email protected]

The information contained herein should in no way be construed or interpreted as a solicitation to sell or offer to sell advisory services. All content is for informational purposes only.

SOURCE TIFIN